Healthcare -
Biotechnology - NASDAQ - US
$ 13.719
3.54 %
$ 199 M
Market Cap
0.11
P/E
INBX - REVENUE
Revenue INBX - Inhibrx Biosciences, Inc.
1.8 M
LAST VALUE
-49.74%
2 YEAR CAGR
-24.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR